Antagonist - PDFSEARCH.IO - Document Search Engine

Antagonist
Results: 956

#	Item
771	Development of fluorophoric and bivalent ligands at OP receptors: mobility and dynamics studies Primary Supervision: Michael Decker Secondary Supervisor: Davide Calebiro Lab webpage: http://www.pharmazie.uni-wuerzburg.de Add to Reading List Source URL: www.graduateschools.uni-wuerzburg.de Language: English - Date: 2014-05-13 11:14:11 Pharmacology Receptors Opioid receptor Ligand Receptor antagonist Receptor Agonist Biology Cell biology Cell signaling
772	NCI Conference: Low Dose Opioid Blockers, Endorphins and Metenkephalins “Promising Compounds for Unmet Medical Needs” Executive Plaza North Bethesda, MD[removed]Attendees Add to Reading List Source URL: lowdosenaltrexone.org Language: English - Date: 2007-07-07 12:12:57 Multiple sclerosis Ketones Alcohols Morphinans Ethers Low-dose naltrexone Naltrexone Opioid antagonist Methadone Chemistry Medicine Organic chemistry
773	Reprod. Human Reproduction pp.Hum. 1–4, 2007 Advance Access published September 12, 2007 Add to Reading List Source URL: ismaar.org Language: English - Date: 2013-06-25 12:36:27 Biology Ovarian hyperstimulation In vitro fertilisation Gonadotropin-releasing hormone antagonist Gonadotropin-releasing hormone agonist Follicle-stimulating hormone Cetrorelix Gonadotropin-releasing hormone Ovulation Human reproduction Fertility medicine Medicine
774	Page 1 of 5 – Granisetron Hydrochloride Tablets IN CASE OF EMERGENCY Emergency Phone: ([removed]Material Safety Data Sheet Add to Reading List Source URL: bi-msds.e3solutionsinc.com Language: English - Date: 2014-04-09 14:10:54 Neurochemistry Ketones Amines Eli Lilly and Company Anorectics Granisetron 5-HT3 antagonist Methadone Serotonin Chemistry Antiemetics Organic chemistry
775	[removed]-597–606$7.00 PHARMACOLOGICAL REVIEWS Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics Pharmacol Rev 55:597–606, 2003 Vol. 55, No. 4 Add to Reading List Source URL: iuphar-db.org Language: English - Date: 2008-02-27 04:26:11 Receptor antagonist Agonist Receptor theory Receptor Ligand Schild regression Intrinsic activity IC50 Drug action Biology Pharmacology Pharmaceutical sciences
776	Microsoft Word - Irbesartan Tablets USP.doc Add to Reading List Source URL: bi-msds.e3solutionsinc.com Language: English - Date: 2014-04-09 14:13:18 Bristol-Myers Squibb Irbesartan Lactams Tetrazoles Methamphetamine Material safety data sheet Dangerous goods Toxic Substances Control Act Angiotensin II receptor antagonist Chemistry Safety Health
777	MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF HYPERTENSION Add to Reading List Source URL: www.aace.com Language: English - Date: 2011-02-15 10:26:17 Essential hypertension Prehypertension Systolic hypertension Antihypertensive drug Blood pressure Thiazide Secondary hypertension Renal artery stenosis Angiotensin II receptor antagonist Hypertension Health Medicine
778	Proposed-CRT-Patient-Product-Information-MK0954-T-Aliskiren-CBE-Feb2013-WORD Add to Reading List Source URL: www.merck.com Language: English - Date: 2013-10-14 10:43:22 Medicine Alcohols Kidney diseases Amides Losartan Diabetic nephropathy Angiotensin II receptor antagonist Diabetes mellitus type 2 Aliskiren Chemistry Organic chemistry Diabetes
779	Low-dose Naltrexone (LDN) Fact Sheet 2013 Naltrexone is a class of drug known as an opiate antagonist. Its normal use is in treating addiction to opiate drugs such as heroin or morphine. The dose used for this purpose is Add to Reading List Source URL: ldnresearchtrust.org Language: English - Date: 2013-10-20 09:06:23 Multiple sclerosis Alcohols Morphinans Ketones Phenols Low-dose naltrexone Naltrexone Autoimmune disease Opioid antagonist Chemistry Organic chemistry Medicine
780	Diabetologia DOI[removed]s00125[removed]z ARTICLE Association of heart failure severity with risk of diabetes: Add to Reading List Source URL: www.diabetologia-journal.org Language: English - Date: 2014-06-17 09:00:56 Anatomy Antihypertensive drug Diabetes mellitus Heart failure Angiotensin II receptor antagonist Valsartan Beta blocker Diabetes management Glycated hemoglobin Diabetes Endocrine system Health